Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

187 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Individualized prognostic calculators in the precision oncology era.
Taylor JMG, Shuman AG, Beesley LJ. Taylor JMG, et al. Among authors: shuman ag. Oncotarget. 2019 Jan 11;10(4):415-416. doi: 10.18632/oncotarget.26581. eCollection 2019 Jan 11. Oncotarget. 2019. PMID: 30728894 Free PMC article. No abstract available.
Demographics and efficacy of head and neck cancer screening.
Shuman AG, Entezami P, Chernin AS, Wallace NE, Taylor JM, Hogikyan ND. Shuman AG, et al. Otolaryngol Head Neck Surg. 2010 Sep;143(3):353-60. doi: 10.1016/j.otohns.2010.05.029. Otolaryngol Head Neck Surg. 2010. PMID: 20723771 Free PMC article.
End-of-life care among head and neck cancer patients.
Shuman AG, Yang Y, Taylor JM, Prince ME. Shuman AG, et al. Otolaryngol Head Neck Surg. 2011 May;144(5):733-9. doi: 10.1177/0194599810397603. Otolaryngol Head Neck Surg. 2011. PMID: 21493350 Free PMC article.
Mucosal melanoma of the head and neck: predictors of prognosis.
Shuman AG, Light E, Olsen SH, Pynnonen MA, Taylor JM, Johnson TM, Bradford CR. Shuman AG, et al. Arch Otolaryngol Head Neck Surg. 2011 Apr;137(4):331-7. doi: 10.1001/archoto.2011.46. Arch Otolaryngol Head Neck Surg. 2011. PMID: 21502471
A phase II trial of the BCL-2 homolog domain 3 mimetic AT-101 in combination with docetaxel for recurrent, locally advanced, or metastatic head and neck cancer.
Swiecicki PL, Bellile E, Sacco AG, Pearson AT, Taylor JM, Jackson TL, Chepeha DB, Spector ME, Shuman A, Malloy K, Moyer J, McKean E, McLean S, Sukari A, Wolf GT, Eisbruch A, Prince M, Bradford C, Carey TE, Wang S, Nör JE, Worden FP. Swiecicki PL, et al. Among authors: shuman a. Invest New Drugs. 2016 Aug;34(4):481-9. doi: 10.1007/s10637-016-0364-5. Epub 2016 May 26. Invest New Drugs. 2016. PMID: 27225873 Free PMC article. Clinical Trial.
Survival Outcomes in Patients with T2N0M0 (Stage II) Squamous Cell Carcinoma of the Larynx.
Gainor DL, Marchiano E, Bellile E, Spector ME, Taylor JMG, Wolf GT, Hogikyan ND, Prince ME, Bradford CR, Eisbruch A, Worden F, Shuman AG. Gainor DL, et al. Among authors: shuman ag. Otolaryngol Head Neck Surg. 2017 Oct;157(4):625-630. doi: 10.1177/0194599817711374. Epub 2017 Jun 13. Otolaryngol Head Neck Surg. 2017. PMID: 28608731 Free PMC article.
187 results